Filippo Pietrantonio

90PUBLICATIONS
519CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Women's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (90)

|Sep 15, 2026
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial.

|Jul 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

|Apr 25, 2026
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer.

|Apr 21, 2026
Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Apr 13, 2026
Circulating Tumor DNA Dynamics in Patients with Liver-Limited Metastatic Colorectal Cancer Resected after First-Line Systemic Treatment.

Roberto Moretto, Vittorio Studiale, Seung Won Hyun

Pageof 15

Frequent Collaborators

38 joint publications

Sara Lonardi

28 joint publications

Chiara Cremolini

16 joint publications

Federica Morano

14 joint publications

Paolo Manca